Enalapril contraindications: Difference between revisions
Gerald Chi (talk | contribs) m Changed protection level for "Enalapril contraindications" ([Edit=Allow only autoconfirmed users] (expires 19:30, 26 February 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 19:30, 26 February 2014 (UTC))) |
Amr Marawan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{CMG}} | __NOTOC__ | ||
{{Enalapril}} | |||
{{CMG}}; {{AE}} {{AM}} | |||
Enalapril maleate is contraindicated in patients who are hypersensitive to this product and in patients with a history of [[angioedema]] related to previous treatment with an [[angiotensin converting enzyme inhibitor]] and in patients with hereditary or [[idiopathic angioedema]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VASOTEC (ENALAPRIL MALEATE) TABLET VASOTEC (ENALAPRIL MALEATE) TABLET [BTA PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d181743-a0fc-4d17-953d-b17a936f9ecc | publisher = | date = | accessdate = }}</ref> | |||
==References== | |||
{{Reflist}} | |||
{{FDA}} | {{FDA}} | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 19:51, 12 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]
Enalapril
Enalapril and Hydrochlorothiazide
Enalapril and Felodipine
Overview
Enalapril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [5]
Enalapril maleate is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema.[1]
References
Adapted from the FDA Package Insert.